← Leaderboards
Mohammad Mohseni Sajadi
University Of Maryland Baltimore
$9,238,668
Attributed
$11,063,567
Total exposure
11
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.2M · FY2010–25$2.5M$1.9M$1.3M$625K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$11,063,567 · 8
VA$0 · 3
By mechanism
R01$9,336,158 · 5
U01$777,495 · 1
K23$538,850 · 1
R56$411,064 · 1
I01$0 · 3
Top collaborators
- Anthony L Devico3 shared
- George K Lewis1 shared
- Scott Dusan Pegan1 shared
Most similar at University Of Maryland Baltimore
Same institution · by research overlap
- Manhattan E Charurat$19,344,390
- William Albert Blattner$260,131,047
- Stefanie N. Vogel$26,533,913
- James B Kaper$25,841,976
- Ligia Peralta$12,857,945
Others in their field
Top investigators on “Antibodies”
- Lawrence Corey · Fred Hutchinson Cancer Center$525,765,536
- Bambra Strokes · Ppd Development Lp$461,655,950
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$385,009,925
- Barton F Haynes · Duke University$372,611,596
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$323,573,074
- Dennis R. Burton · Scripps Research Institute$306,733,901
Research focus
AntibodiesCellsNeutralizing AntibodyVaccinesAntigensInfectionPlasmaMonoclonal AntibodiesHiv-1Hiv InfectionsPreventResponseVirusPreventionPersonsHiv Envelope Protein Gp120MediatingBaseInterestX-Ray CrystallographyEpitopesSuccessCharacteristicsFamily
Grant awards (36)
Molecular determinants of vaccine-induced antibody durability$777,495
U01 · FY2025 · AI · contact PI
Identification of GP38 and NP antibodies and their protective mechanisms against CCHFV$738,880
R01 · FY2025 · AI
Isolation of broadly protective monoclonal antibodies for Crimean Congo Hemorrhagic Fever$611,747
R01 · FY2025 · AI · contact PI
Isolation of broadly protective monoclonal antibodies for Crimean Congo Hemorrhagic Fever$58,536
R01 · FY2025 · AI · contact PI
Isolation of broadly protective monoclonal antibodies for Crimean Congo Hemorrhagic Fever$685,980
R01 · FY2024 · AI · contact PI
Novel bNAB-based treatment and prevention of HIV-1$657,954
R01 · FY2024 · AI · contact PI
Engineering of pan-neutralizing anti-HIV envelope antibodies$385,595
R01 · FY2024 · AI · contact PI
COVID-19: Elucidating monoclonal and polyclonal seroantibody responses to the COVID-19 viral envelope$0
I01 · FY2024 · VA · contact PI
Novel bNAB-based treatment and prevention of HIV-1$766,942
R01 · FY2023 · AI · contact PI
Engineering of pan-neutralizing anti-HIV envelope antibodies$401,045
R01 · FY2023 · AI · contact PI
COVID-19: Elucidating monoclonal and polyclonal seroantibody responses to the COVID-19 viral envelope$0
I01 · FY2023 · VA · contact PI
Engineering of broadly reactive seroantibodies$0
I01 · FY2023 · VA · contact PI
Novel bNAB-based treatment and prevention of HIV-1$629,056
R01 · FY2022 · AI · contact PI
Engineering of pan-neutralizing anti-HIV envelope antibodies$529,941
R01 · FY2022 · AI · contact PI
Engineering of broadly reactive seroantibodies$0
I01 · FY2022 · VA · contact PI
COVID-19: Elucidating monoclonal and polyclonal seroantibody responses to the COVID-19 viral envelope$0
I01 · FY2022 · VA · contact PI
Novel bNAB-based treatment and prevention of HIV-1$737,425
R01 · FY2021 · AI · contact PI
Engineering of pan-neutralizing anti-HIV envelope antibodies$603,410
R01 · FY2021 · AI · contact PI
Engineering of broadly reactive seroantibodies$0
I01 · FY2021 · VA · contact PI
Engineering of pan-neutralizing anti-HIV envelope antibodies$610,897
R01 · FY2020 · AI · contact PI
Long-lived plasma cells in HIV infection and vaccination$411,064
R56 · FY2020 · AI · contact PI
Engineering of broadly reactive seroantibodies$0
I01 · FY2020 · VA · contact PI
HIV-1 acidic epitope discovery from broadly neutralizing seroantibodies$383,750
R01 · FY2019 · AI · contact PI
Discovery of acidic epitopes for HIV-1 broadly neutralizing seroantibodies$0
I01 · FY2019 · VA · contact PI
HIV-1 acidic epitope discovery from broadly neutralizing seroantibodies$383,750
R01 · FY2018 · AI · contact PI
Discovery of acidic epitopes for HIV-1 broadly neutralizing seroantibodies$0
I01 · FY2018 · VA · contact PI
HIV-1 acidic epitope discovery from broadly neutralizing seroantibodies$383,750
R01 · FY2017 · AI · contact PI
Discovery of acidic epitopes for HIV-1 broadly neutralizing seroantibodies$0
I01 · FY2017 · VA · contact PI
HIV-1 acidic epitope discovery from broadly neutralizing seroantibodies$383,750
R01 · FY2016 · AI · contact PI
Discovery of acidic epitopes for HIV-1 broadly neutralizing seroantibodies$0
I01 · FY2016 · VA · contact PI
HIV-1 acidic epitope discovery from broadly neutralizing seroantibodies$383,750
R01 · FY2015 · AI · contact PI
Discovery of acidic epitopes for HIV-1 broadly neutralizing seroantibodies$0
I01 · FY2015 · VA · contact PI
The circulating and memory B-antibody responses in HIV-infected patients$134,660
K23 · FY2013 · AI · contact PI
The circulating and memory B-antibody responses in HIV-infected patients$134,730
K23 · FY2012 · AI · contact PI
The circulating and memory B-antibody responses in HIV-infected patients$134,730
K23 · FY2011 · AI · contact PI
The circulating and memory B-antibody responses in HIV-infected patients$134,730
K23 · FY2010 · AI · contact PI